000			01951 a2200541 4500
005			20250513084642.0
264		0	_c19960305
008			199603s 0 0 eng d
022			_a0022-1899
024	7		_a10.1093/infdis/173.2.330 _2doi
040			_aNLM _beng _cNLM
100	1		_aGorse, G J
245	0	0	_aA dose-ranging study of a prototype synthetic HIV-1MN V3 branched peptide vaccine. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group. _h[electronic resource]
260			_bThe Journal of infectious diseases _cFeb 1996
300			_a330-9 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAIDS Vaccines _xadministration & dosage
650	0	4	_aAdult
650	0	4	_aAmino Acid Sequence
650	0	4	_aDose-Response Relationship, Immunologic
650	0	4	_aDouble-Blind Method
650	0	4	_aEnzyme-Linked Immunosorbent Assay
650	0	4	_aFemale
650	0	4	_aHIV Antibodies _xanalysis
650	0	4	_aHIV Envelope Protein gp120 _xchemistry
650	0	4	_aHIV-1 _ximmunology
650	0	4	_aHumans
650	0	4	_aLymphocyte Activation
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMolecular Sequence Data
650	0	4	_aNeutralization Tests
650	0	4	_aPeptide Fragments _xchemistry
700	1		_aKeefer, M C
700	1		_aBelshe, R B
700	1		_aMatthews, T J
700	1		_aForrest, B D
700	1		_aHsieh, R H
700	1		_aKoff, W C
700	1		_aHanson, C V
700	1		_aDolin, R
700	1		_aWeinhold, K J
700	1		_aFrey, S E
700	1		_aKetter, N
700	1		_aFast, P E
773	0		_tThe Journal of infectious diseases _gvol. 173 _gno. 2 _gp. 330-9
856	4	0	_uhttps://doi.org/10.1093/infdis/173.2.330 _zAvailable from publisher's website
999			_c8567367 _d8567367